Triamterene and Hydrochlorothiazide Capsules recall: Impurity Out of Spec
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10
Why was Triamterene and Hydrochlorothiazide Capsules recalled?
Failed Impurity/Degradation Specifications
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: 21000279A (exp 01/2023), 20256320A (12/2022)
- Product
- Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10
- Recalling firm
- Lannett Company Inc.
- Quantity
- 20,040 bottles
- Distribution
- Nationwide USA
- Recall date
- January 25, 2023
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)